|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2023
Volume 8 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 8
Issue Published : 84
Article Submitted : 17592
Article Published : 5245
Total Authors : 13542
Total Reviewer : 835
Total Countries : 129
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A Review Article On Asthma |
| Authors Name: | Majid Mukhtar , Firdous Ahmed , Omer Fakhereldeen , H.C Patil , Avneet Garg |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_182098
|
| Published Paper Id: | IJNRD2207084 |
| Published In: | Volume 7 Issue 7, July-2022 |
| DOI: | |
| Abstract: | Asthma is a heterogenic disorder that is poorly understood and undertreated, despite the fact that effective treatments and the analytical tools necessary to understand it are both readily available. To effectively treat patients with recurrent nasal or sinus irritation, suppliers must have a working understanding of asthma. The foundation of this article focuses on the present aetiology of asthma, including its definition, potential causes, explosive characteristics, pathophysiology, subtypes, and associated disorders. Despite the fact that asthma affects roughly 8% of adults, the majority of these people have a mild to moderate infection that is treatable with the right care. Considering that, it is estimated that 5–10% of asthmatics have severe infections that are difficult to treat. Therapeutics, including corticosteroids. |
| Keywords: | Asthma, Pathophysiology, Treatment |
| Cite Article: | "A Review Article On Asthma", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 7, page no.687-693, July-2022, Available :http://www.ijnrd.org/papers/IJNRD2207084.pdf |
| Downloads: | 000111419 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2207084 Registration ID: 182098 Published In: Volume 7 Issue 7, July-2022 DOI (Digital Object Identifier): Page No: 687-693 Country: Bathinda, Punjab, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2207084 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2207084 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2023 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn